RE:RE:RE:Stock Target Price $24.00Wow, you mean it has only been months of solid bullshite S80, sure feels more like much longer. I imagine your short position would be substantial if you had standing and could sell short? The dog has a better chance of selling short than you and even she knows better.
Green close on mild volume, it appears that you and the rest of the barking clown show speak for nothing and no one, just noise as usual. JMHO...Opt
Starsearcher80 wrote: Wow, I've been saying $24 for how many months now? But wait OptRed...that's $24 Canadian. ;)
OptGreen wrote: And Piper knows Dar? One man's opinion, therory plus "ex acquisitions"...very thin at best. There is far more to see in the FQ1/22 report that will speak to the reality of the company and it's current standing.
I'll be 'looking out' for the report, just like Piper...could it hit $24, absolutely and what a buying opportunity if that should happen. This company is a much different animal today than at time in the past and there will be much different results going forward. Klein/team will realize profit and by mid '22 will be no surprise. The weak and profitless management of the past is just that, the past.
Looking like a green close today and anywhere in the $20s is buying oppotunity going forward. Everyone needs to do their DD and buy, sell, hold accordingly. JMHO...Opt
02:24 PM EDT, 07/08/2021 (MT Newswires) -- Piper Sandler's Michael Lavery has kept its Neutral rating on Canopy Growth, and lowered its one year price target to US$24, from US$27, as it expects modest sequential top-line declines in Q1 2022 as COVID restrictions and provincial inventory de-loading to continue to weigh on gains. The analyst expects store growth in Canada to drive gains in F22, though a 50% lift in store count likely translates to something closer to ~20% sales growth for Canopy (ex-acquisitions), as geographic mix, product mix and SKU rationalizations drive a lower level of wholesale sales gains.
Lavery has also trimmed 2022 sales from ~$735 million to ~$690 million and cutting $1,000 million 2023 sales estimate to $890 million. Q1 2022 revenue outlook has also been lowered, from $151 million to $141 million.
Canopy has dual Canadian headwinds, as market share weakness and inventory reductions by provincial boards look like a bigger drag than anticipated, driving a $8 million cut to estimates. Provinces are rationalizing SKUs. In the US, Canopy's Q4 2021 Biosteel sell-in to distributors is a headwind that had been recognized, but Lavery is now trimming US$2-3 million more from estimates to be more conservative.
Pricing competition remains intense in Canada for recreational use products. Piper Sandler still projects SG&A as a percent of sales to steadily decline, but at a slower pace.
Darholio wrote: When the price goes to below $27 look out!!
I would expect that to happen today.